The National Psoriasis Foundation (NPF) will recognize Craig Leonardi, M.D., at the 2020 Commit to Cure Gala in St. Louis for his tireless efforts to support and help people living with psoriasis and psoriatic arthritis. NPF is proud to honor Leonardi, a leading dermatologist and expert in psoriatic disease, with a Lifetime Achievement Award.

As a member of the NPF medical board and a strong advocate on behalf of patients, Leonardi helps to address the challenges faced by people with psoriatic disease and fights for improved access to care, more research support and improved treatment options.

We hope you will join us on Dec. 5, 2020, for this spectacular evening of fine dining, entertainment and a live auction!

Craig Leonardi, M.D., is adjunct professor of dermatology at St. Louis University Medical School in St. Louis, Missouri, where he also has a private practice, Central Dermatology.

He received his medical degree from the University of Miami School of Medicine in Florida and completed an internship in pediatrics and residency in dermatology at the University of Miami/Jackson Memorial Hospital. His medical career has allowed him many opportunities to advance the treatment of psoriasis on a large scale and he remains passionate about bringing new, effective treatments to his patients.

Leonardi has been an invited speaker for NPF at national, regional and state dermatology meetings. He has been involved in more than 200 clinical trials, predominately for psoriasis, and has published more than 250 articles and abstracts in the Journal of the American Academy of Dermatology, the British Journal of Dermatology, Archives of Dermatology, the Journal of the American Medical Association, the New England Journal of Medicine and the Lancet. 

Leonardi is certified by the American Board of Dermatology and is a member of the American Dermatological Association. He received a Presidential Citation from the American Academy of Dermatology in 2016. He is a fellow of the AAD and a member of the AAD-NPF Psoriasis Guidelines committee. He is also a co-founder and board member of the International Psoriasis Council.